A

Atrium Therapeutics

Develops RNA drugs for rare genetic heart diseases

Senior Clinical Scientist

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeSan Diego, CA, USAHybrid

About the Job

Requirements

  • An advanced degree: PhD, MD, or PharmD.
  • At least 8 years of relevant experience, including at least 3 years of clinical science experience in a pharmaceutical or biotechnology environment.
  • Rare disease and/or cardiology experience.
  • Expert knowledge of scientific principles and concepts, with publication, peer-review, or scientific conference presentation experience.
  • Knowledge of clinical trial design; ability to assimilate technical and scientific information; and proficiency in data analysis and interpretation.
  • Experience contributing to clinical and regulatory documents.
  • Interpersonal, written and verbal communication, presentation, organizational, and workload-prioritization skills.
  • Ability to perform in a deadline-driven environment, support multiple projects simultaneously, and work effectively on cross-functional teams.

Responsibilities

  • Contribute to the planning and design of clinical studies in accordance with corporate objectives.
  • Provide scientific support through literature searches, interpretation of scientific literature, and evaluation of technologies that aid clinical strategy, study implementation, and due diligence.
  • Contribute to clinical oversight and scientific review of trial data, including the analysis and interpretation of efficacy and safety data.
  • Support the Study Medical Monitor in tracking laboratory results and communicating with site staff.
  • Collaborate with Clinical Operations to translate protocols into operational deliverables, review study data, and prepare or review study plans.
  • Draft, review, and revise clinical documents, including protocols, clinical study reports, informed consent forms, investigator brochures, annual reports, and regulatory submission materials.
  • Contribute to cross-functional and clinical meetings, including study team, investigator, site initiation, ad hoc, and steering committee meetings.
  • Complete required training, including training relating to security, regional data protection requirements, GxP, and SOPs, in a timely manner.

About the Company

Atrium Therapeutics

Develops RNA drugs for rare genetic heart diseases

Atrium Therapeutics develops RNA-based therapies for rare, life-threatening genetic heart diseases. It aims to deliver RNA drugs specifically to heart muscles, using a proprietary platform that pairs tissue-targeting monoclonal antibodies with oligonucleotides for precise genetic modulation. Unlike broader biopharma players, Atrium focuses on cardiomyopathies with no approved treatments and operates at the preclinical stage with two main candidates, ATR 1072 (PRKAG2 syndrome) and ATR 1086 (PLN cardiomyopathy), plus undisclosed targets. The company’s goal is to treat the underlying genetic causes of these diseases and bring therapies to patients who currently have no options.

Company size
51-200
Company stage
IPO
Headquarters
San Diego, CA
Founded
2025

Recently Posted Jobs

Explore more opportunities at Atrium Therapeutics

See more jobs